scispace - formally typeset
G

Gordon L. Amidon

Researcher at University of Michigan

Publications -  469
Citations -  38521

Gordon L. Amidon is an academic researcher from University of Michigan. The author has contributed to research in topics: Intestinal absorption & Prodrug. The author has an hindex of 86, co-authored 466 publications receiving 35880 citations. Previous affiliations of Gordon L. Amidon include ETH Zurich & Merck & Co..

Papers
More filters
Journal ArticleDOI

An improved synthesis of a fluorophosphonate-polyethylene glycol-biotin probe and its use against competitive substrates.

TL;DR: A novel synthetic route to a known FP probe linked by polyethylene glycol to a biotin tag (FP–PEG–biotin) markedly increases the efficiency of the probe synthesis and overcomes several problems of a prior synthesis.
Journal ArticleDOI

The feasibility of enzyme targeted activation for amino acid/dipeptide monoester prodrugs of floxuridine; cathepsin D as a potential targeted enzyme.

TL;DR: It is feasible to design prodrugs which are activated by specific enzymes, and cathepsin D might be a good candidate as a target enzyme for prodrug activation and 5′-O-L-phenylalanyl- L-tyrosylfloxuridine may be the best candidate among the tested floxuidine prodrugS.
Journal ArticleDOI

Some general influences of n-decylmethyl sulfoxide on the permeation of drugs across hairless mouse skin.

TL;DR: Permeability coefficients obtained with stripped skin indicated that, where NDMS has its maximal effect, the compounds diffuse through the skin as if there were no stratum corneum.
Journal ArticleDOI

Cytomegalovirus protease targeted prodrug development.

TL;DR: The results of this research demonstrate that targeting prodrugs for activation by a specific protease encoded by the infectious HCMV pathogen may be achievable.
Journal ArticleDOI

The Dipeptide Monoester Prodrugs of Floxuridine and Gemcitabine—Feasibility of Orally Administrable Nucleoside Analogs

TL;DR: Cell proliferation assays in ductal pancreatic cancer cells indicated that dipeptide prodrugs of floxuridine and gemcitabine were more potent than their parent drugs and enhanced potency of nucleoside analogs was attributed to their improved membrane permeability.